Programme Introduction
About this programme
💊 Pharmacy Practice
✅ Regulatory & Clinical
📋 Case-Based Learning
Signal detection and risk management sit at the more advanced end of pharmacovigilance practice, moving beyond individual case reporting into assessing a drug’s overall benefit-risk balance across its patient population.
This work depends on systematic benefit-risk assessment methodology and structured Risk Management Plans (RMPs) that define how identified risks will be monitored and minimised over a product’s lifecycle.
TerraLeap’s Signal Detection & Risk Management course is designed for pharmacovigilance and drug-safety professionals, covering benefit-risk assessment and RMPs.
The course covers systematic benefit-risk assessment methodology, structured Risk Management Plan development, and ongoing risk minimisation monitoring throughout a product’s lifecycle.
Clinical and regulatory expertise — built for real pharmacy practice.
Programme Scope
What this programme covers
This course covers benefit-risk and RMPs for signal detection and risk management.
⚖️
Benefit-risk assessment
Systematic methodology for assessing a drug’s overall benefit-risk balance.
📋
Risk Management Plans
Structuring RMPs that define risk monitoring and minimisation activities.
📊
Signal evaluation
Evaluating detected signals to determine appropriate action.
🔄
Lifecycle monitoring
Ongoing risk minimisation monitoring throughout a product’s lifecycle.
⚠️
Risk communication
Communicating identified risks clearly to regulators and prescribers.
📈
Data synthesis
Synthesising safety data from multiple sources for risk assessment.
🌍
Regulatory expectations
Understanding regulatory expectations for RMP submission and updates.
Learning Objectives
What you will achieve
After completing this course, learners will be able to apply benefit-risk assessment methodology and develop Risk Management Plans in pharmacovigilance practice.
Each objective addresses a core signal detection and risk management competency.
01
Apply systematic methodology for assessing a drug’s overall benefit-risk balance
02
Structure Risk Management Plans that define monitoring and minimisation activities
03
Evaluate detected signals to determine appropriate action
04
Apply ongoing risk minimisation monitoring throughout a product’s lifecycle
05
Communicate identified risks clearly to regulators and prescribers
06
Synthesise safety data from multiple sources for risk assessment
07
Understand regulatory expectations for RMP submission and updates
Target Audience
Who can enroll
This course is designed for pharmacovigilance and drug-safety professionals working on signal detection and risk management.
Whether your role is signal evaluation or risk management planning, this course strengthens advanced pharmacovigilance competency.
🔬
Pharmacovigilance professionals conducting signal evaluation
⚖️
Drug-safety professionals developing Risk Management Plans
📊
Safety scientists supporting benefit-risk assessment
🎓
Professionals advancing into senior pharmacovigilance roles
📋
Regulatory affairs teams supporting RMP submissions
Programme Certification
Your certificate
Upon successful completion of this programme, you will receive a digital certificate recognising your achievement and the competencies you have acquired throughout the course.
Certificates for TerraLeap programmes are issued and signed by authorised TerraLeap representatives. For programmes delivered in collaboration with universities, institutions, or industry organisations, certificates are jointly issued and co-signed by authorised representatives of both TerraLeap and the respective partner.
Each certificate carries a unique Certificate ID and QR code to enable instant authenticity verification — making it easy to share with employers, licensing bodies, or professional networks as evidence of your learning.
Note on scope. TerraLeap certificates confirm successful completion of the respective programme and recognise your professional development and continuing education. They do not constitute a professional licence or regulatory authorisation unless explicitly stated in the programme description.
TERRALEAP
Certificate ID
TL-2026-AB7K3X9P
Official
Seal
Certificate of Completion
Successfully Completed
Awarded in recognition of academic achievement
This is to certify that
XXXXX
has successfully completed the prescribed course of study, demonstrating commitment, diligence, and proficiency in
Signal Detection and Risk Management in Pharmacovigilance
and is hereby awarded this certificate by TerraLeap, recognising the candidate's mastery of the syllabus and successful evaluation.